Unusual Machines, Inc. UMAC
We take great care to ensure that the data presented and summarized in this overview for Unusual Machines, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in UMAC
Top Purchases
Top Sells
About UMAC
Insider Transactions at UMAC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Allan Thomas Evans Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,087
-6.28%
|
$11,087
$1.99 P/Share
|
|
Dec 29
2025
|
Allan Thomas Evans Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,789
+27.14%
|
$65,789
$1.99 P/Share
|
|
Dec 29
2025
|
Sanford Rich Director |
SELL
Open market or private sale
|
Direct |
11,087
-5.13%
|
$11,087
$1.99 P/Share
|
|
Dec 29
2025
|
Sanford Rich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,789
+23.34%
|
$65,789
$1.99 P/Share
|
|
Dec 29
2025
|
Robert Paul Lowry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,895
+17.45%
|
$32,895
$1.99 P/Share
|
|
Dec 12
2025
|
Brian Joseph Hoff Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,000
-15.29%
|
$750,000
$10.31 P/Share
|
|
Dec 12
2025
|
Andrew Ross Camden Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-16.34%
|
$500,000
$10.32 P/Share
|
|
Nov 20
2025
|
Allan Thomas Evans Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
250,000
+17.2%
|
-
|
|
Nov 20
2025
|
Brian Joseph Hoff Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-1.75%
|
$78,750
$9.1 P/Share
|
|
Nov 20
2025
|
Brian Joseph Hoff Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+20.02%
|
-
|
|
Nov 20
2025
|
Cristina Colon Director |
SELL
Open market or private sale
|
Direct |
8,268
-13.56%
|
$74,412
$9.06 P/Share
|
|
Nov 20
2025
|
Andrew Ross Camden Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,750
-2.78%
|
$78,750
$9.1 P/Share
|
|
Nov 20
2025
|
Andrew Ross Camden Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+28.43%
|
-
|
|
Aug 21
2025
|
Brian Joseph Hoff Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
33,750
-8.27%
|
$337,500
$10.21 P/Share
|
|
Aug 21
2025
|
Andrew Ross Camden Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
35,000
-15.57%
|
$350,000
$10.21 P/Share
|
|
Aug 20
2025
|
Brian Joseph Hoff Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-2.1%
|
$78,750
$9.8 P/Share
|
|
Aug 20
2025
|
Andrew Ross Camden Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.75%
|
$78,750
$9.8 P/Share
|
|
Aug 19
2025
|
Robert Paul Lowry Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,308
+50.0%
|
-
|
|
Aug 19
2025
|
Jeffrey M Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,308
+0.68%
|
-
|
|
Aug 19
2025
|
Cristina Colon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,308
+3.65%
|
-
|
Last 12 Months Summary
Buy / Acquisition
1.52M
Shares
From
10
Insiders
| Grant, award, or other acquisition | 1.36M shares |
|---|---|
| Exercise of conversion of derivative security | 164K shares |
Sell / Disposition
403K
Shares
From
5
Insiders
| Open market or private sale | 403K shares |
|---|